IceCure Medical Ltd ICCM
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 72.76% | 46.17% | -48.07% | -2.42% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 72.76% | 46.17% | -48.07% | -2.42% | |
| Cost of Revenue | 65.99% | 48.25% | -18.09% | 6.96% | |
| Gross Profit | 93.13% | 43.88% | -75.28% | -18.96% | |
| SG&A Expenses | 44.54% | -22.39% | -16.94% | 12.35% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 36.34% | 1.76% | -7.76% | -0.25% | |
| Operating Income | -30.69% | 6.83% | -4.86% | -0.19% | |
| Income Before Tax | -33.80% | 5.20% | -9.19% | 0.58% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -33.80% | 5.20% | -9.19% | 0.58% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -33.80% | 5.20% | -9.19% | 0.58% | |
| EBIT | -30.69% | 6.83% | -4.86% | -0.19% | |
| EBITDA | -31.00% | 6.71% | -5.63% | -0.08% | |
| EPS Basic | 15.23% | 26.89% | 8.88% | 19.43% | |
| Normalized Basic EPS | 15.23% | 26.88% | 8.87% | -- | |
| EPS Diluted | 15.23% | 26.89% | 8.88% | 19.43% | |
| Normalized Diluted EPS | 15.23% | 26.88% | 8.87% | -- | |
| Average Basic Shares Outstanding | 57.83% | 29.66% | 19.82% | 23.33% | |
| Average Diluted Shares Outstanding | 57.83% | 29.66% | 19.82% | 23.33% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |